Mayo Clinic Exact Sciences Corp Transaction History

Mayo Clinic

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$62.68 - $95.05 $124,357 - $188,579	-1,984 Reduced 38.52%	3,167 $297,000
Q1 2023 May 05, 2023	BUY	$47.19 - $70.77 $70,596 - $105,871	1,496 Added 40.93%	5,151 $349,000
Q4 2022 Jan 26, 2023	BUY	$30.35 - $53.15 $110,929 - $194,263	3,655 New	3,655 $181 Million
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $152,007 - $202,133	-1,304 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$99.61 - $142.12 $197,725 - $282,108	-1,985 Reduced 60.35%	1,304 $173,000
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $239,833 - $335,510	3,289 New	3,289 $3.35 Million
Q2 2020 Aug 13, 2020	SELL	$55.75 - $92.75 $211,571 - $351,986	-3,795 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$77.66 - $99.74 $294,719 - $378,513	3,795 New	3,795 $351,000

667

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.91B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Mayo Clinic, based on Form 13F filings with the SEC.

Stay updated on Mayo Clinic with notifications on news.